T. Skorski

发表

Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells.

G. Zon, B. Calabretta, M. Ratajczak, 1995, Blood.

Advances in the biology and therapy of chronic myeloid leukemia (CML): Proceedings from the 6 th Post-ASH International CML and Myeloproliferative Neoplasms Workshop

J. Radich, D. Scadden, G. Martinelli, 2013 .

Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases.

B. Calabretta, R. Iozzo, D. Mann, 1997, The Journal of clinical investigation.

De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells.

T Skorski, B Calabretta, B. Calabretta, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Regulation of proliferation and cytokine expression of bone marrow fibroblasts: role of c-myb

B. Calabretta, L. Rudnicka, T. Skorski, 1993, The Journal of experimental medicine.

Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and c-myb promoter activity

B Calabretta, C. Peschle, B. Calabretta, 1995, Molecular and cellular biology.

Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes

Z. Darżynkiewicz, G. Zon, B. Calabretta, 1995, The Journal of experimental medicine.

Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth

G. Zon, B. Calabretta, E. Canaani, 1994, The Journal of experimental medicine.

Growth factor-dependent inhibition of normal hematopoiesis by N-ras antisense oligodeoxynucleotides

B. Calabretta, M. Ratajczak, A. Gewirtz, 1992, The Journal of experimental medicine.

Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines.

B. Calabretta, T. Skorski, S. Pucci, 1992, Cancer research.

Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides.

B. Calabretta, A. Gewirtz, T. Skorski, 1991, Science.

Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase.

B. Calabretta, P. Włodarski, M. Wasik, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides.

B. Calabretta, P. Włodarski, G. Hoser, 1997, Journal of the National Cancer Institute.

The role of c-Myc protooncogene in chronic myelogenous leukemia.

B. Calabretta, M. Nieborowska-Skorska, Ratajczak Mz, 1994, Folia histochemica et cytobiologica.

The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing.

B. Calabretta, P. Salomoni, P. Włodarski, 1998, Blood.

Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.

D. Lloyd, B. Calabretta, T. Skorski, 1996, Nucleic acids research.

BCR/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac.

P Salomoni, T Skorski, P Wlodarski, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and c-myb promoter activity

C. Peschle, B. Calabretta, D. Perrotti, 1995, Molecular and cellular biology.

Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide.

P. Iversen, G. Zon, B. Calabretta, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Antisense strategies in the treatment of leukemias.

B. Calabretta, M. Ratajczak, A. Gewirtz, 1996, Seminars in oncology.